Westlake University’s AI-designed drug wins first approval in China
The drug took about three and a half years to reach approval, far shorter than the traditional drug-development timeline.
The drug took about three and a half years to reach approval, far shorter than the traditional drug-development timeline.

The new campus will be part of Zhejiang University’s existing Zijingang Campus, rather than a separate university campus.

This release could potentially transform one of regenerative medicine’s most labor-intensive research processes.

Westlake Therapeutics is the first commercialization spinout from Westlake University, focused on engineered red blood cell therapeutics and industrial development.
与团队成员李佳轶(右)、曹兴。-受访者供图.jpg)
A one-million-tonne-class HMF production facility in Zhejiang was structurally completed in December, laying groundwork for potential scaling of plant-based plastics.